Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
Health Technology Assessment2003Vol. 7(14), pp. 1–88
Citations Over TimeTop 1% of 2003 papers
Jenny Donovan, Freddie C. Hamdy, David E. Neal, T. J. Peters, Samuel J. Oliver, Lucy Brindle, David Jewell, Philip Powell, David Gillatt, Daniel Dedman, Nicola Mills, Monica Smith, Sian Noble, J. Athene Lane, ProtecT Study Group
Abstract
T he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.
Related Papers
- → Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story(2020)21 cited
- Time Trends in NICE HTA Decisions(2012)
- → PCN154 A COMPARISON OF HTA RECOMMENDATIONS FOR CANCER TREATMENT TECHNOLOGIES PUBLISHED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)(2010)1 cited
- Implementation of UK NICE's technology evaluation and clinical guidelines and its implication(2011)
- → HTA260 Informal Carer Disutility: How Many Caregivers Are Captured in Cost-Utility Analyses of Treatments for Rare Diseases Submitted for NICE Highly Specialised Technology Appraisals?(2022)